A LOOK INSIDE IMPERIAL COLLEGE’S TTO: Imperial Innovations

Project information

Index: 1210R4
Acronym:ETTBio
Priority:1: Innovation and the knowledge economy
Sub Theme:Innovation, research and technology development
Location UNITED KINGDOM LONDON London Inner London Start/End date of the practice
Start: 2006
End: N/A

Topic of the practice

Technology transfer, TTO structure

Good Practice Information

Imperial Innovations (II) makes an important distinction between TTO activities (technology transfer team) and investment activities (ventures team). The technology transfer team at II is responsible for assessing, managing and beginning the commercialisation process for intellectual property developed at Imperial College London.
The Ventures team at II operates across the healthcare and technology sectors, and is dedicated to building businesses. Where a company has been established, they will work to ensure the appointment of high quality management, the development of strong relationships with industry, and will utilise their extensive operational expertise to provide the best possible platform for growth.

Evidence of success

We considered this practice as good because of its extraordinary performance: In the period from 2005 – 2010 II counted 800 biotech disclosures, 150 patent applications of which around 40 biotech patents were issued. The net assets are estimated at 276 mil EUR while the TTO raised 249 mil EUR since 2005. The total revenues were 5.2 mil EUR. In total 51 patents were filed in 2012.

Contact details to obtain further information on the practice

Dr. Robin De Cock

Imperial College London Business School

r.de-cock@imperial.ac.uk

wwwf.imperial.ac.uk/business-school/

Annex completed on: 09-17-2014

As of 31 December 2015, this website is no longer updated. Follow news on interregional cooperation at www.interregeurope.eu